Circulating miR-652-3p as a biomarker of resistance to regorafenib in metastatic colorectal cancer patients

被引：1
|
作者：
Hedayat, Somaieh [1 ]
Khan, Khurum [2 ]
Cunningham, David [2 ]
Vlachogiannis, George [1 ]
Lampis, Andrea [1 ]
Marchetti, Silvia [1 ]
Fassan, Matteo [3 ]
Begum, Ruwaida [2 ]
Schirripa, Marta [4 ]
Loupakis, Fotios Fotios [4 ]
Valeri, Nicola [1 ]
机构：
[1] Inst Canc Res, London, England
[2] Royal Marsden Hosp, London, England
[3] Univ Padua, Padua, Italy
[4] Ist Oncol Veneto, Padua, Italy
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-LB-305
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-305
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Circulating miR-652-3p as a biomarker of drug resistance in metastatic colorectal cancer patients
    Hedayat, S.
    Lampis, A.
    Vlachogiannis, G.
    Khan, K.
    Cunningham, D.
    Marchetti, S.
    Fassan, M.
    Begum, R.
    Schirripa, M.
    Loupakis, F.
    Valeri, N.
    ANNALS OF ONCOLOGY, 2019, 30
  • [2] Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
    Hedayat, Somaieh
    Cascione, Luciano
    Cunningham, David
    Schirripa, Marta
    Lampis, Andrea
    Hahne, Jens C.
    Tunariu, Nina
    Hong, Sung Pil
    Marchetti, Silvia
    Khan, Khurum
    Fontana, Elisa
    Angerilli, Valentina
    Delrieux, Mia
    Rodrigues, Daniel Nava
    Procaccio, Letizia
    Rao, Sheela
    Watkins, David
    Starling, Naureen
    Chau, Ian
    Braconi, Chiara
    Fotiadis, Nicos
    Begum, Ruwaida
    Guppy, Naomy
    Howell, Louise
    Valenti, Melanie
    Cribbes, Scott
    Kolozsvari, Bernadett
    Kirkin, Vladimir
    Lonardi, Sara
    Ghidini, Michele
    Passalacqua, Rodolfo
    Elghadi, Raghad
    Magnani, Luca
    Pinato, David J.
    Di Maggio, Federica
    Ghelardi, Filippo
    Sottotetti, Elisa
    Vetere, Guglielmo
    Ciraci, Paolo
    Vlachogiannis, Georgios
    Pietrantonio, Filippo
    Cremolini, Chiara
    Cortellini, Alessio
    Loupakis, Fotios
    Fassan, Matteo
    Valeri, Nicola
    CLINICAL CANCER RESEARCH, 2024, 30 (10) : 2140 - 2159
  • [3] MiR-652-3p promotes bladder cancer migration and invasion by targeting KCNN3
    Zhu, Q-L
    Zhan, D-M
    Chong, Y-K
    Ding, L.
    Yang, Y-G
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (20) : 8806 - 8812
  • [4] Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib
    Vincenzo Ricci
    Cristina Granetto
    Antonella Falletta
    Matteo Paccagnella
    Andrea Abbona
    Elena Fea
    Teresa Fabozzi
    Cristiana Lo Nigro
    Marco Carlo Merlano
    World Journal of Gastrointestinal Oncology, 2020, (03) : 301 - 310
  • [5] Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib
    Ricci, Vincenzo
    Granetto, Cristina
    Falletta, Antonella
    Paccagnella, Matteo
    Abbona, Andrea
    Fea, Elena
    Fabozzi, Teresa
    Lo Nigro, Cristiana
    Merlano, Marco Carlo
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (03) : 301 - 310
  • [6] Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer
    Nonaka, Ryoji
    Nishimura, Junichi
    Kagawa, Yoshinori
    Osawa, Hideki
    Hasegawa, Junichi
    Murata, Kohei
    Okamura, Shu
    Ota, Hirofumi
    Uemura, Mamoru
    Hata, Taishi
    Takemasa, Ichiro
    Mizushima, Tsunekazu
    Okuzaki, Daisuke
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Mori, Masaki
    ONCOLOGY REPORTS, 2014, 32 (06) : 2354 - 2358
  • [7] Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib
    Schirripa, M.
    Loupakis, F.
    Cremolini, C.
    Poliseno, L.
    Salvatore, L.
    Tuccoli, A.
    Antoniotti, C.
    D'Aurzio, R.
    Marmorino, F.
    Borelli, B.
    Rossini, D.
    Saettini, A.
    Gini, S.
    Moretto, R.
    Rizzo, I.
    Aquila, E. Dell'
    Pellegrini, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26
  • [8] Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib
    Antoniotti, C.
    Loupakis, F.
    Schirripa, M.
    Cremolini, C.
    Poliseno, L.
    Salvatore, L.
    Tuccoli, A.
    D'Aurizio, R.
    Marmorino, F.
    Borelli, B.
    Rossini, D.
    Saettini, A.
    Gini, S.
    Moretto, R.
    Rizzo, I.
    Dell'Aquila, E.
    Pellegrini, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 37 - 38
  • [9] Regorafenib in metastatic colorectal cancer: An exploratory biomarker trial.
    Salem, Mohamed E.
    Petricoin, Emanuel
    Wellstein, Anton
    Pierobon, Mariaelena
    Wang, Hongkun
    Mikhail, Sameh
    Hartley, Marion L.
    Smaglo, Brandon George
    Lou, Emil
    Alistar, Angela Tatiana
    Dorsch-Vogel, Karen
    Pishvaian, Michael J.
    He, Aiwu Ruth
    Kim, Alexander Y.
    Shivapurkar, Narayan
    Reddy, Sandeep K.
    Marshall, John
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [10] Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib
    Marta Schirripa
    Beatrice Borelli
    Romina D’Aurizio
    Simone Lubrano
    Chiara Cremolini
    Gemma Zucchelli
    Carlotta Antoniotti
    Federica Marmorino
    Alessandra Anna Prete
    Sabina Murgioni
    Francesca Bergamo
    Vittorina Zagonel
    Andrea Tuccoli
    Andrea Marranci
    Milena Rizzo
    Lorena Tedeschi
    Letizia Magnoni
    Alfredo Falcone
    Fotios Loupakis
    Laura Poliseno
    The Pharmacogenomics Journal, 2019, 19 : 455 - 464
12345